Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytokinetics (CYTK)
NASDAQ:CYTK
Cytokinetics (CYTK) Stock Forecast & Price Target
969 Followers
See the Price Targets and Ratings of:
CYTK Analyst Ratings
Strong Buy
13 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CYTK Stock 12 Month Forecast
Average Price Target
$85.14
▲(55.25% Upside)
| Highest Price Target$107.00 | Average Price Target$85.14 | Lowest Price Target$60.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
06/17/24
Truist Financial
Reiterated
06/06/24
B.Riley Financial
Reiterated
06/04/24
JMP Securities
Reiterated
05/31/24
Bank of America Securities
Reiterated
05/23/24
Mizuho Securities
$99
Buy
80.53%
Upside
Assigned
05/23/24
Wall Street Analysts Are Bullish on Top Healthcare Picks
Leerink Partners
$92→$88
Buy
60.47%
Upside
Assigned
05/22/24
Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (NASDAQ: PYXS), Hims & Hers Health (NYSE: HIMS) and Cytokinetics (NASDAQ: CYTK)
Oppenheimer
$106
Buy
93.29%
Upside
Reiterated
05/14/24
Oppenheimer Remains a Buy on Cytokinetics (CYTK)
Morgan Stanley
$70
Hold
27.64%
Upside
Reiterated
05/13/24
Cytokinetics data confirm aficamten's competitive profile, says Morgan StanleyCytokinetics data confirm aficamten's competitive profile, says Morgan Stanley
Goldman Sachs
$85
Buy
55.00%
Upside
Reiterated
05/13/24
Buy Rating Affirmed for Cytokinetics on Strong SEQUOIA-HCM Study Results and Favorable Market Prospects
Best Analysts Covering Cytokinetics
Which Analyst Should I Follow If I Want to Buy CYTK and Sell After:
1 Month
3 Months
1 Year
Success Rate
19/26 ratings generated profit
Average Return
+34.43%
reiterated a buy rating 6 months ago
Copying Charles Duncan's trades and holding each position for 1 Year would result in 73.08% of your transactions generating a profit, with an average return of +34.43% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CYTK Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
11
5
5
21
24
Buy
37
26
22
20
19
Hold
5
4
3
6
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
53
35
30
47
49
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
CYTK Financial Forecast
CYTK Stock Forecast FAQ
What is CYTK’s average 12-month price target, according to analysts?
Based on analyst ratings, Cytokinetics’s 12-month average price target is $85.14.
What is CYTK’s upside potential, based on the analysts’ average price target?
Cytokinetics has 55.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CYTK a Buy, Sell or Hold?
Cytokinetics has a consensus rating of Strong Buy which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.
What is Cytokinetics’s price target?
The average price target for Cytokinetics is $85.14. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $107.00 ,the lowest forecast is $60.00. The average price target represents 55.25% Increase from the current price of $54.84.
The highest analyst price target is $107.00 ,the lowest forecast is $60.00. The average price target represents 55.25% Increase from the current price of $54.84.
What do analysts say about Cytokinetics?
Cytokinetics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of CYTK?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.